Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaping Wu

Showing results (281-290 of 287) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 287 results.
Archives of Pathology & Laboratory Medicine|July 25, 2019
Predictive Markers Require Thorough Analytic ValidationMegan L Troxell, Regan S Fulton, Paul E Swanson, et al.
JCI Insight|June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcomaJianguo Huang, Xingliang Liu, Warren Floyd, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast CancerDavid B Page, Joanna Pucilowska, Katherine G Sanchez, et al.
NPJ Breast Cancer|June 21, 2023
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancerDavid B Page, Joanna Pucilowska, Brie Chun, et al.
The Lancet. Oncology|August 11, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trialTomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, et al.
Nature|February 4, 2026
Parkinson's disease as a somato-cognitive action network disorderJianxun Ren, Wei Zhang, Louisa Dahmani, et al.
Pageof 29

Showing results (281-290 of 287) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 287 results.
Archives of Pathology & Laboratory Medicine|July 25, 2019
Predictive Markers Require Thorough Analytic ValidationMegan L Troxell, Regan S Fulton, Paul E Swanson, et al.
JCI Insight|June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcomaJianguo Huang, Xingliang Liu, Warren Floyd, et al.
NPJ Breast Cancer|March 18, 2026
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancerAlan Su, Erin C Hong, Nicole Moxon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast CancerDavid B Page, Joanna Pucilowska, Katherine G Sanchez, et al.
NPJ Breast Cancer|June 21, 2023
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancerDavid B Page, Joanna Pucilowska, Brie Chun, et al.
The Lancet. Oncology|August 11, 2022
Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trialTomoko Yamazaki, Andrew J Gunderson, Miranda Gilchrist, et al.
Nature|February 4, 2026
Parkinson's disease as a somato-cognitive action network disorderJianxun Ren, Wei Zhang, Louisa Dahmani, et al.
Pageof 29